Contact us:
+1 (520) 226-8615
Email:
[email protected]
NR 602 Soap Note -Juvenile RA
Juvenile Idiopathic Arthritis (Juvenile RA)
JIA, formerly known as juvenile rheumatoid arthritis (JRA), now encompasses several disorders that have a common feature of arthritis (e.g., enthesitis-related arthritis and psoriatic arthritis) and had not been identified under the nomenclature of JRA (Wu et?al, 2011). The diagnosis of JIA requires a persistent arthritis for more than 6 weeks in a pediatric patient younger than 16 years old. Table 25-1 shows the most current classification system.
TABLE 25-1
Juvenile Idiopathic Arthritis Subtypes and Clinical Joint Characteristics
Juvenile Idiopathic Arthritis Subtype | Clinical Joint Characteristics |
Oligoarticular | Four or less joints with persistent disease never having more than four-joint involvement and extended disease progressing to more than four joints within the first 6 months |
Polyarticular (RF negative) | Five or more joints with symmetrical involvement |
Polyarticular (RF positive) | Symmetric involvement of both small and large joints with erosive joint disease |
Systemic | Either polyarticular or oligoarticular disease |
Enthesitis-related arthritis | Weight-bearing joints involved especially hip and intertarsal joints and a history of back pain, which is inflammatory in nature or sacroiliac joint involvement |
Psoriatic arthritis | Asymmetric or symmetric small or large joints |
Undifferentiated |
RF, Rheumatoid factor.
The underlying cause of most forms of JIA is unclear; however, it is a heterogenous disorder. It is likely environmentally induced in genetically predisposed …
NR 602 Soap Note -Juvenile RA
The presence of autoantigens from cartilage and joint tissue leads to activation of the T cells and results in release of proinflammatory …
NR 602 Soap Note -Juvenile RA
Clinical Findings
History
The major complaints in all forms of JIA are from the arthritis characterized by:
Systemic symptoms are found more commonly in systemic and polyarticular subtypes and include anemia, anorexia, fever, fatigue, lymphadenopathy, salmon-colored rash (SJIA), and weight loss. Growth abnormalities can result in localized growth disturbances, including premature fusion of the epiphyses, bony overgrowth (rheumatoid nodules), and limb-length discrepancies.
NR 602 Soap Note -Juvenile RA
Physical Examination
Associated features are:
Less commonly seen are ocular disease (e.g., iridocyclitis, iritis, or uveitis), pleuritis, pericarditis, anemia of chronic disease, fatigue, and growth failure, or leg-length discrepancy if the arthritis is unilateral.
Key physical findings are:
There are five major types of JIA (Gowdie and Tse, 2012):
NR 602 Soap Note -Juvenile RA
Diagnostic Studies
JIA is a diagnosis of exclusion. The diagnosis is based on physical findings and history of arthritis lasting for 6 weeks or longer. There is no diagnostic laboratory test for JIA. Most children with oligoarticular …
Differential Diagnosis
The various causes of monoarticular arthritis are part of the differential diagnosis. However, Lyme disease must be excluded and other differentials, including tumors, leukemia, cancer, bacterial infections, toxic synovitis, rheumatic fever, SLE, spondyloarthropathies, inflammatory bowel disease, septic arthritis, and chondromalacia patellae, need to be carefully considered.
NR 602 Soap Note -Juvenile RA
Management
A specialist in pediatric rheumatology should follow children with severe involvement. Ophthalmology referral and evaluation is critical in a child with a positive ANA. Uveitis needs immediate ophthalmologic management. It is most common in oligoarticular JIA and is highly associated with a positive ANA. Other pediatric subspecialists, such as orthopedists, pain management specialists, and cardiologists, may be consulted as needed. Therapy depends on the degree of local or systemic involvement.
ORDER NOW FOR A CUSTOM-WRITTEN, PLAGIARISM-FREE PAPER WITH ALL INSTRUCTIONS FOLLOWED
The main treatment goals are to suppress inflammation, preserve and maximize joint function, prevent joint deformities, …
Pharmacologic agents commonly used in the management of JIA include the following (Gowdie and Tse, 2012):
NR 602 Soap Note -Juvenile RA
Complications and Prognosis
Systemic involvement can include iridocyclitis, uveitis, pleuritis, pericarditis, anemia, fatigue, and hepatitis. Residual joint damage caused by granulation of tissue in the joint space can occur. Children most likely to develop permanent crippling disability include those with hip involvement, unremitting synovitis, or positive-RF test.
The course of the disease is variable, and there is no curative treatment. Again, early aggressive treatment is critical; therefore, referral to a specialist is important. After an initial episode, the child may never have another episode, or the disease may go into remission and recur months or years later. The disease process of JIA wanes with age and completely subsides in 85% of children; however, systemic onset, a positive RF, poor response to therapy, and the radiologic evidence of erosion are associated with a poor prognosis. Onset of disease in the teenage years is related to progression to adult rheumatoid disease.